PMID 24009505
Exploring the Concerns: European Medicines Agencys Alert The alert issued by the European Medicines Agency (EMA) regarding the use of glucagon-like peptide-1 (GLP-1) receptor agonists, notably semaglutide, highlights the critical need for continuous monitoring of medication safety
In general, collagen supplements arent recommended for those at a high risk of developing kidney stones
Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM, Capozzi ME, Van derVelden WJ, Stutsman C, Cardona GR, Urva S, Emmerson PJ, Holst JJ, DAlessio DA, Coghlan MP, Rosenkilde MM, Campbell JE, Sloop KW
Clinical trials and many user reports show early changes in appetite as the body responds to slower gastric emptying and altered hunger signaling